Nexgel Inc
NASDAQ:NXGL

Watchlist Manager
Nexgel Inc Logo
Nexgel Inc
NASDAQ:NXGL
Watchlist
Price: 4.73 USD 2.38%
Market Cap: 35.6m USD
Have any thoughts about
Nexgel Inc?
Write Note

Nexgel Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nexgel Inc
Accounts Payable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Nexgel Inc
NASDAQ:NXGL
Accounts Payable
$1.2m
CAGR 3-Years
23%
CAGR 5-Years
50%
CAGR 10-Years
N/A
Haemonetics Corp
NYSE:HAE
Accounts Payable
$69.2m
CAGR 3-Years
15%
CAGR 5-Years
4%
CAGR 10-Years
5%
ICU Medical Inc
NASDAQ:ICUI
Accounts Payable
$168.6m
CAGR 3-Years
40%
CAGR 5-Years
6%
CAGR 10-Years
30%
Align Technology Inc
NASDAQ:ALGN
Accounts Payable
$109m
CAGR 3-Years
-15%
CAGR 5-Years
11%
CAGR 10-Years
16%
Lantheus Holdings Inc
NASDAQ:LNTH
Accounts Payable
$44.9m
CAGR 3-Years
30%
CAGR 5-Years
22%
CAGR 10-Years
11%
Merit Medical Systems Inc
NASDAQ:MMSI
Accounts Payable
$60.8m
CAGR 3-Years
6%
CAGR 5-Years
3%
CAGR 10-Years
9%
No Stocks Found

Nexgel Inc
Glance View

Market Cap
35.6m USD
Industry
Health Care

NexGel, Inc. engages in the manufacture of polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania. The company went IPO on 2021-12-22. The firm is engaged in the manufactures of high-water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The firm specializes in custom gels by capitalizing on manufacturing technologies. Its products are manufactured by using proprietary and non-proprietary mixing, coating and cross-linking technologies. The company operates as a contract manufacturer of aqueous polymer hydrogels. The company delivers medication through hydrogel patches. Its Hydrogel patches are used for transdermal applications, such as hormone replacement therapy and contraception, treatment of acne, shingles, diabetes, motion sickness, treatment of angina with nitroglycerin and treatment of smoking addiction.

NXGL Intrinsic Value
7.73 USD
Undervaluation 39%
Intrinsic Value
Price

See Also

What is Nexgel Inc's Accounts Payable?
Accounts Payable
1.2m USD

Based on the financial report for Dec 31, 2023, Nexgel Inc's Accounts Payable amounts to 1.2m USD.

What is Nexgel Inc's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
50%

Over the last year, the Accounts Payable growth was 357%. The average annual Accounts Payable growth rates for Nexgel Inc have been 23% over the past three years , 50% over the past five years .

Back to Top